JSR Life Sciences

We are excited to have a speaker from our affiliate company, KBI Biopharma, a global CDMO, present on the new high-productivity cell culture medium. Through the acquisition of affiliate companies, our life sciences division has become a leading source of life sciences research products and services worldwide. By converging JSRs leading position in materials innovation with JSR Life Sciences best-in-class companies, the Company is in a unique position to deliver on the promise of digital health by making medicines more personalized and precise. JSR jointly acquired KBI Biopharma, Inc., a contract developer and manufacturers of biopharmaceuticals in the United States. JSR-Keio University Medical and Chemical Innovation Center (JKiC) is founded. As part of a continued effort to identify and accelerate novel therapies and innovative technologies, JSR established a corporate venture fund. The fund focuses on early stage, innovative biotech companies developing transformative disease therapies and diagnostic tools and breakthrough discovery and development platforms. JSR Life Sciences launches Similis Bio, a biosimilar development offering.